Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03382093 · ClinicalTrials.gov registry record · NA
Personalized Feedback for Smokers With Elevated Anxiety Sensitivity
A NA study of Anxiety and Anxiety Disorders, sponsored by University of Houston.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 1
- Study location
NCT03382093: Completed NA study of Anxiety and Anxiety Disorders, sponsored by University of Houston.
NCT03382093 is a NA study of Anxiety and Anxiety Disorders that has completed, run by University of Houston. The registered enrollment target is 95 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03382093, a NA study of Anxiety and Anxiety Disorders, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will develop and refine a computer-delivered integrated Personalized Feedback Intervention (PFI) that directly addresses smoking and anxiety sensitivity (AS). The PFI will focus on feedback about smoking behavior, AS, and adaptive coping strategies.
Primary Outcome
Evaluate the protocol for a brief personalized, computer-delivered intervention. Assessed by program evaluation survey.
Conditions Studied
Interventions
- BEHAVIORAL Personalized Feedback Intervention
- BEHAVIORAL Smoking Information Control
Study Locations (1)
Texas
- Anxiety and Health Research Laboratory and Substance Use Treatment Clinic, University of Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2017-08-23 |
| Est. Completion | 2019-06-01 |
| Phase | NA |
What the finished NCT03382093 record still lists
NCT03382093 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (78% lower).
The record links to 5 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Personalized Feedback Intervention is the first listed.
NCT03382093 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03382093 about?
NCT03382093 is a clinical study titled "Personalized Feedback for Smokers With Elevated Anxiety Sensitivity". This project will develop and refine a computer-delivered integrated Personalized Feedback Intervention (PFI) that directly addresses smoking and anxiety sensitivity (AS). The PFI will focus on feedback about smoking behavior, AS, and adaptive coping strategies.
What is the current status of trial NCT03382093?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2017-08-23. Estimated completion is 2019-06-01.
What conditions does trial NCT03382093 study?
This clinical trial studies the following conditions: Anxiety, Anxiety Disorders, Tobacco Dependence, Smoking, Cigarette, Smoking, Tobacco.
What interventions are being tested in trial NCT03382093?
The interventions under investigation include: Personalized Feedback Intervention (BEHAVIORAL), Smoking Information Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT03382093?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03382093 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03382093's enrollment target sits among peer trials
95 181st of 364 higher than 182 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI